4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-020283
Options or other derivatives
- Chief Scientific Officer acquired 620,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Sumen Cenk Chief Scientific Officer | 2022-04-11 | Grant or award · Employee Stock Option (right to buy) | +500,000 | 500,000 | D: show line 1 in the form | |||||
| Sumen Cenk Chief Scientific Officer | 2023-03-20 | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | D: show line 2 in the form |
Loading xslF345X04/doc4.xml…